Zalupski M - Search Results

1

Zalupski M, Baker LH. Zalupski M, et al. J Natl Cancer Inst. 1988 Jun 15;80(8):556-66. doi: 10.1093/jnci/80.8.556. J Natl Cancer Inst. 1988. PMID: 3286879 Review.

2

Randomized phase II evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (G-CSF) compared with 12 g/m2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcoma.

Worden FP, Taylor JM, Biermann JS, Sondak VK, Leu KM, Chugh R, McGinn CJ, Zalupski MM, Baker LH. Worden FP, et al. Among authors: zalupski mm. J Clin Oncol. 2005 Jan 1;23(1):105-12. doi: 10.1200/JCO.2005.05.108. J Clin Oncol. 2005. PMID: 15625365 Clinical Trial.

3

Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma.

Chugh R, Wagner T, Griffith KA, Taylor JM, Thomas DG, Worden FP, Leu KM, Zalupski MM, Baker LH. Chugh R, et al. Among authors: zalupski mm. Cancer. 2007 Jun 1;109(11):2315-22. doi: 10.1002/cncr.22669. Cancer. 2007. PMID: 17464949 Free article. Clinical Trial.

4

A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcoma.

Davis EJ, Chugh R, Zhao L, Lucas DR, Biermann JS, Zalupski MM, Feng M, Wong SL, Jacobson J, Zyczynski L, Reinke D, Metko G, Baker LH, Schuetze SM. Davis EJ, et al. Among authors: zalupski mm. Eur J Cancer. 2015 Sep;51(13):1794-802. doi: 10.1016/j.ejca.2015.05.010. Epub 2015 Jun 9. Eur J Cancer. 2015. PMID: 26066736 Clinical Trial.

5

Ifosfamide and etoposide in the treatment of advanced soft tissue sarcomas.

Blair SC, Zalupski MM, Baker LH. Blair SC, et al. Among authors: zalupski mm. Am J Clin Oncol. 1994 Dec;17(6):480-4. doi: 10.1097/00000421-199412000-00005. Am J Clin Oncol. 1994. PMID: 7977164 Clinical Trial.

6

Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study.

Zalupski M, Metch B, Balcerzak S, Fletcher WS, Chapman R, Bonnet JD, Weiss GR, Ryan J, Benjamin RS, Baker LH. Zalupski M, et al. J Natl Cancer Inst. 1991 Jul 3;83(13):926-32. doi: 10.1093/jnci/83.13.926. J Natl Cancer Inst. 1991. PMID: 2067035 Clinical Trial.

7

Phase II study of 9-nitro-camptothecin in patients with advanced chordoma or soft tissue sarcoma.

Chugh R, Dunn R, Zalupski MM, Biermann JS, Sondak VK, Mace JR, Leu KM, Chandler WF, Baker LH. Chugh R, et al. Among authors: zalupski mm. J Clin Oncol. 2005 May 20;23(15):3597-604. doi: 10.1200/JCO.2005.02.170. J Clin Oncol. 2005. PMID: 15908670 Clinical Trial.

8

SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy.

Davis EJ, Zhao L, Lucas DR, Schuetze SM, Baker LH, Zalupski MM, Thomas D, Chugh R. Davis EJ, et al. Among authors: zalupski mm. BMC Cancer. 2016 Aug 20;16:663. doi: 10.1186/s12885-016-2694-2. BMC Cancer. 2016. PMID: 27544129 Free PMC article. Clinical Trial.

9

A common cytogenetic abnormality and DNA content alterations in dedifferentiated chondrosarcoma.

Zalupski MM, Ensley JF, Ryan J, Selvaggi S, Baker LH, Wolman SR. Zalupski MM, et al. Cancer. 1990 Sep 15;66(6):1176-82. doi: 10.1002/1097-0142(19900915)66:6<1176::aid-cncr2820660617>3.0.co;2-k. Cancer. 1990. PMID: 2400969

10

Systemic adjuvant chemotherapy for soft tissue sarcomas.

Zalupski MM, Baker LH. Zalupski MM, et al. Hematol Oncol Clin North Am. 1995 Aug;9(4):787-800. Hematol Oncol Clin North Am. 1995. PMID: 7490241 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters